参考文献/References:
[1] Di Angelantonio E,Kaptoge S,Wormser D,et al. Association of cardiometabolicmultimorbidity with mortality[J]. JAMA, 2015,314(1):52-60.
[2] Boudina S,Abel ED. Diabetic cardiomyopathy,causes and efects[J]. Rev Endocr Metab Disord,2010,11(1):31-39.
[3] Abel ED,O'Shea KM,Ramasamy R. Insulin resistance:metabolic mechanisms and consequences in the heart[J]. Arterioscler Thromb Vasc Biol,2012,32(9):2068-2076.
[4] Bugger H,Abel ED. Molecular mechanisms of diabetic cardiomyopathy[J].Diabetologia,2014,57(4):660-671.
[5] Stratmann B,Tschoepe D. Heart in diabetes:not only a macrovasculardisease[J]. Diabetes Care,2011,34(Suppl 2):S138-S414.
[6] Li C,Zhang J,Xue M,et al. SGLT2 inhibition with empaglifozin attenuates myocardial oxidative stress andfbrosis in diabetic mice heart[J]. Cardiovasc Diabetol,2019,18(1):15.
[7] Baartscheer A,Schumacher CA,Wust RC,et al. Empaglifozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits[J]. Diabetologia,2017,60(3):568-573.
[8] Lambert R,Srodulski S,Peng X,et al.Intracellular Na+ concentration([Na+]i)is elevated in diabetichearts due to enhanced Na+-glucose cotransport[J]. J Am Heart Assoc,2015,4(9):e002183.
[9] Banerjee SK,Mc Gafn KR,Pastor-Soler NM,et al. SGLT1 is a novelcardiac glucose transporter that is perturbed in disease states[J]. Cardiovasc Res,2009,84(1):111-118.
[10] Uthman L,Baartscheer A,Schumacher CA,et al. Direct cardiacactions of sodium glucose cotransporter 2 inhibitors target pathogenicmechanisms underlying heart failure in diabetic patients[J]. Front Physiol,2018(9):1575.
[11] Suzuki H,Kayama Y,Sakamoto M,et al. Arachidonate 12/15-lipoxygenaseinduced infammation and oxidative stress are involved in the development of diabetic cardiomyopathy[J]. Diabetes,2015,64(2):618-630.
[12] Hutchinson KR,Lord CK,West TA,et al. Cardiac fbroblastdependent extracellular matrix accumulation is associated with diastolicstifness in type 2 diabetes[J]. PLoS ONE,2013,8(8):e72080.
[13] 刘毅龙,陈鹏宇,雷 江,等. SGLT-2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J]. 陕西医学杂志,2019,48(3):407-409.
相似文献/References:
[1]杨 鲲,何 勇△,孙 静.比伐卢定与普通肝素对冠心病合并2型糖尿病患者经皮冠状动脉介入术凝血功能的影响研究*[J].陕西医学杂志,2020,49(9):1157.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.026]
YANG Kun,HE Yong,SUN Jing..Effect of bivalirudin and unfractionated heparin on coagulation function in patients with coronary heart disease complicated with type 2 diabetes mellitus undergoing PCI[J].,2020,49(7):1157.[doi:DOI:10.3969/j.issn.1000-7377.2020.09.026]
[2]马 明,谢华宁,张军茹.达格列净治疗2型糖尿病合并慢性心力衰竭临床疗效观察[J].陕西医学杂志,2021,50(1):93.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.025]
[3]杨 旭,张致英,康龙丽,等.环状RNA与代谢性疾病研究进展[J].陕西医学杂志,2021,50(1):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
YANG Xu,ZHANG Zhiying,KANG Longli,et al.Advances in circular RNA and metabolic diseases[J].,2021,50(7):126.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.033]
[4]杨 璐,于敬妮,张 赟,等.空腹血糖水平与免疫性葡萄膜炎发病相关性调查研究[J].陕西医学杂志,2021,50(5):630.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.029]
[5]罗诒财,李 昊.糖尿病患者种植体周围炎治疗研究进展[J].陕西医学杂志,2021,50(10):1318.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.036]
LUO Yicai,LI Hao.Advances in the treatment of peri-implantitis in diabetic patients[J].,2021,50(7):1318.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.036]
[6]李 琳,马红侠.血清25羟维生素D与肥胖/超重糖尿病患者合并甲状腺功能亢进相关性研究[J].陕西医学杂志,2022,51(1):70.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.018]
[7]姜 飞,王东玉.依达拉奉右莰醇联合尿激酶静脉溶栓治疗急性脑梗死合并糖尿病对患者血清氧化应激水平、颈总动脉内-中膜厚度、血清基质金属蛋白酶-12水平的影响[J].陕西医学杂志,2022,51(1):88.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]
JIANG Fei,WANG Dongyu.Effects of edaravone dexborneol combined with urokinase intravenous thrombolysis on serum oxidative stress,common carotid artery intra-media thickness and serum MMP-12 in patients with acute cerebral infarction and diabetes mellitus[J].,2022,51(7):88.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.023]
[8]马昱杭,韩昀屹,韩者艺.顶端钠依赖性胆酸转运体及其在相关疾病中的作用研究进展[J].陕西医学杂志,2022,51(9):1163.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.028]
MA Yuhang,HAN Yunyi,HAN Zheyi.Advances in apical sodium-dependent bile acid transporter and its role in related diseases[J].,2022,51(7):1163.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.028]
[9]吕艳红,刘朵朵,李 佳.新型冠状病毒奥密克戎变异株感染轻型及无症状患者核酸转阴时间影响因素分析[J].陕西医学杂志,2022,51(12):1511.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.010]
[10]梁 蒙,杨 雀,陈伟国,等.达格列净联合阿托伐他汀治疗糖尿病心肌病疗效及对患者Klotho和心室重构的影响[J].陕西医学杂志,2023,52(7):898.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.028]
LIANG Meng,YANG Que,CHEN Weiguo,et al.Efficacy of dapagliflozin combined with atorvastatin in treatment of diabetes cardiomyopathy and effects on Klotho and ventricular remodeling in patients[J].,2023,52(7):898.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.028]